Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distri...

FDA Recall #D-0170-2021 — Class II — December 9, 2020

Recall #D-0170-2021 Date: December 9, 2020 Classification: Class II Status: Terminated

Product Description

Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01

Reason for Recall

CGMP Deviations

Recalling Firm

Akebia Therapeutics dba Keryx Biopharmaceutials, Inc — Cambridge, MA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2,170 bottles

Distribution

The product was distributed by two major distributors who further distributed the product nationwide and one specialty pharmacy.

Code Information

Lot Number: 9062, exp. date Feb 2021

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls